By Tom Zanki ( March 13, 2015, 1:04 PM EDT) -- Canadian drug giant Valeant Pharmaceuticals International Inc. on Friday priced an upsized $10.1 billion bond offering to fund its planned acquisition of Salix Pharmaceuticals Ltd., also being courted by rival Endo Pharmaceuticals Ltd., the latest mega-deal potentially shaking the drug landscape....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.